{"url":"https://lda.gov/api/v1/filings/ebc2d79c-1486-4c32-b51b-0934c5a525a5/","filing_uuid":"ebc2d79c-1486-4c32-b51b-0934c5a525a5","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/ebc2d79c-1486-4c32-b51b-0934c5a525a5/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John Michael Edward Gray","dt_posted":"2026-05-01T10:07:56-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1105 Montgomery St","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Laurel","registrant_state":"MD","registrant_zip":"20707","registrant":{"id":401109311,"url":"https://lda.gov/api/v1/registrants/401109311/","house_registrant_id":66896,"name":"TULIPIFERA STRATEGIES","description":null,"address_1":"1105 Montgomery St","address_2":null,"address_3":null,"address_4":null,"city":"Laurel","state":"MD","state_display":"Maryland","zip":"20707","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN MICHAEL EDWARD GRAY","contact_telephone":"+1 270-348-0066","dt_updated":"2026-03-05T13:13:04.027516-05:00"},"client":{"id":67407,"url":"https://lda.gov/api/v1/clients/67407/","client_id":67407,"name":"TREATMENT ADVOCACY CENTER","general_description":"Advocacy, education, and research related to eliminating barriers to the treatment of SMI.","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medicaid IMD Exclusion. The IMD Exclusion, within Sec. 1905(a) of the Social Security Act, generally excludes federal fund participation for treatment provided in an inpatient psychiatric facility. Medicare lifetime limit on impatient psychiatric care. Medicare generally imposes a 190 day lifetime limit on treatment provided in an inpatient psychiatric facility.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150276,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"GRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}